The plasma gelsolin levels in atopic dermatitis: Effect of atopy and disease severity

Allergologia et Immunopathologia

Volumn 44, Issue 3, 2016, Pages 221-225

  Eke Gungor, Hatice ^a   Sahiner, Umit Murat ^a   Karakukcu, Cigdem ^a   Sahiner, Neriman ^a   Altuner Torun, Yasemin ^a  

^a KAYSERI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Apoptosis; Atopic dermatitis; Gelsolin; Inflammation

Indexed keywords

GELSOLIN; IMMUNOGLOBULIN E;

ARTICLE; ATOPIC DERMATITIS; ATOPY; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE SEVERITY ASSESSMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; FEMALE; HUMAN; IMMUNOLOGIST; INFANT; MAJOR CLINICAL STUDY; MALE; PRICK TEST; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCORAD INDEX; SKIN PRICK TESTING; APOPTOSIS; BLOOD; CASE CONTROL STUDY; DERMATITIS, ATOPIC; EOSINOPHIL; IMMUNOLOGY; KERATINOCYTE; LEUKOCYTE COUNT; PATHOLOGY; RANDOMIZATION; SEVERITY OF ILLNESS INDEX; SKIN TEST; TURKEY;

APOPTOSIS; CASE-CONTROL STUDIES; DERMATITIS, ATOPIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; FEMALE; GELSOLIN; HUMANS; IMMUNOGLOBULIN E; INFANT; KERATINOCYTES; LEUKOCYTE COUNT; MALE; PROSPECTIVE STUDIES; RANDOM ALLOCATION; SEVERITY OF ILLNESS INDEX; SKIN TESTS; TURKEY;

EID: 84940056494     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2015.05.005     Document Type: Article

References (26)

1. Tollefson M.M., Bruckner A.L. Dection on dermatology: section on dermatology. Pediatrics 2014, 134:1735-1744.
2. Trautmann A., Akdis M., Kleemann D., Altznauer F., Simon H.U., Graeve T., et al. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest 2000, 106:25-35.
3. dos Remedios C.G., Chhabra D., Kekic M., Dedova I.V., Tsubakihara M., Berry D.A., et al. Actin binding proteins: regulation of cytoskeletal microfilaments. Physiol Rev 2003, 83:433-473.
4. Maniatis N.A., Harokopos V., Thanassopoulou A., Oikonomou N., Mersinias V., Witke W., et al. Am J Respir Cell Mol Biol 2009, 41:426-432.
5. Li G.H., Arora P.D., Chen Y., McCulloch C.A., Liu P. Multifunctional roles of gelsolin in health and diseases. Med Res Rev 2012, 32:999-1025.
6. Koya R.C., Fujita H., Shimizu S., Ohtsu M., Takimoto M., Tsujimoto Y., et al. Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochrome c release. J Biol Chem 2000, 275:15343-15349.
7. Kusano H., Shimizu S., Koya R.C., Fujita H., Kamada S., Kuzumaki N., et al. Human gelsolin prevents apoptosis by inhibiting apoptotic mitochondrial changes via closing VDAC. Oncogene 2000, 19:4807-4814.
8. Kothakota S., Azuma T., Reinhard C., Klippel A., Tang J., Chu K., et al. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 1997, 278:294-298.
9. Bucki R., Byfield F.J., Kulakowska A., McCormick M.E., Drozdowski W., Namiot Z., et al. Extracellular gelsolin binds lipoteichoic acid and modulates cellular response to proinflammatory bacterial wall components. J Immunol 2008, 181:4936-4944.
10. Osborn T.M., Dahlgren C., Hartwig J.H., Stossel T.P. Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin. Am J Physiol Cell Physiol 2007, 292:1323-1330.
11. Peddada N., Sagar A., Ashish Garg R. Plasma gelsolin: a general prognostic marker of health. Med Hypotheses 2012, 78:203-210.
12. Shi S., Chen C., Zhao D., Liu X., Cheng B., Wu S., et al. The role of plasma gelsolin in cardiopulmonary bypass induced acute lung injury in infants and young children: a pilot study. BMC Anesthesiol 2014, 14:67.
13. Wang H., Cheng B., Chen Q., Wu S., Lv C., Xie G., et al. Time course of plasma gelsolin concentrations during severe sepsis in critically ill surgical patients. Crit Care 2008, 12:106.
14. Nakane T., Nakamae H., Kamoi H., Koh H., Takeoka Y., Sakamoto E., et al. Prognostic value of serum surfactant protein D level prior to transplant for the development of bronchiolitis obliterans syndrome and idiopathic pneumonia syndrome following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2008, 42:43-49.
15. Suhler E., Lin W., Yin H.L., Lee W.M. Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock, and myonecrosis. Crit Care Med 1997, 25:594-598.
16. Osborn T.M., Verdrengh M., Stossel T.P., Tarkowski A., Bokarewa M. Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis. Arthritis Res Ther 2008, 10:117.
17. Janciauskiene S., Olejnicka B., Koczulla R., Cardell L.O., Welte T., Westin U. Allergen-specific immunotherapy increases plasma gelsolin levels. Am J Rhinol Allergy 2014, 28:136-140.
18. Kawamoto S., Suzuki T., Aki T., Katsutani T., Tsuboi S., Shigeta S., et al. Der f 16: a novel gelsolin-related molecule identified as an allergen from the house dust mite, Dermatophagoides farinae. FEBS Lett 2002, 516:234-238.
19. Candiano G., Bruschi M., Pedemonte N., Caci E., Liberatori S., Bini L., et al. Gelsolin secretion in interleukin-4-treated bronchial epithelia and in asthmatic airways. Am J Respir Crit Care Med 2005, 172:1090-1096.
20. Hanifin J.M., Rajka G. Diagnostic features of atopic dermatitis. Acta Dermato-Venereologica 1980, 92:44-47.
21. Oranje A.P., Glazenburg E.J., Wolkerstorfer A., de Waardvan der Spek F.B. Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score. Br J Dermatol 2007, 157:645-648.
22. Silacci P., Mazzolai L., Gauci C., Stergiopulos N., Yin H.L., Hayoz D. Gelsolin superfamily proteins: key regulators of cellular function. Cell Mol Life Sci 2004, 61:2614-2623.
23. Rothenbach P.A., Dahl B., Schwartz J.J., O'Keefe G.E., Yamamoto M., Lee W.M., et al. Recombinant plasma gelsolin infusion attenuates burn-induced pulmonary microvascular dysfunction. J Appl Physiol 2004, 96:25-31.
24. Lee P.S., Drager L.R., Stossel T.P., Moore F.D., Rogers S.O. Relationship of plasma gelsolin levels to outcomes in critically ill surgical patients. Ann Surg 2006, 243:399-403.
25. Bucki R., Georges P.C., Espinassous Q., Funaki M., Pastore J.J., Chaby R., et al. Inactivation of endotoxin by human plasma gelsolin. Biochemistry 2005, 44:9590-9597.
26. Vasconcellos C.A., Allen P.G., Wohl M.E., Drazen J.M., Janmey P.A., Stossel T.P. Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin. Science 1994, 263:969-971.